Tumor Susceptibility Gene 101 (TSG101) Peptide
TSG101
Reactivity: Human, Mouse
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN985662
Quick Overview for Tumor Susceptibility Gene 101 (TSG101) Peptide (ABIN985662)
Target
TSG101
(Tumor Susceptibility Gene 101 (TSG101))
Origin
Human, Mouse
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-TSG101 antibody (Catalog #: ARP37310_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
-
Background
-
TSG101 has a direct role in the control of growth and differentiation in primary epithelial cells. It is required for normal cell function of embryonic and adult tissues but that this gene is not a tumor suppressor for sporadic forms of breast cancer.
Alias Symbols: CC2, AI255943
Protein Interaction Partner: Gmcl1
Protein Size: 391 -
Molecular Weight
- 43 kDa
-
Gene ID
- 22088
-
NCBI Accession
- NM_021884, NP_068684
-
UniProt
- Q61187
Target
-
You are here:
